The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B contract pharmacy law. The law preserves 340B discounts for drugs dispensed at community pharmacies. 

The AHA also filed friend-of-the-court briefs in the Southern District of Mississippi prior to the court’s denial of the injunctions in July. The AHA has filed briefs in similar cases elsewhere, including in the U.S. Court of Appeals for the 8th Circuit, which upheld a similar law in Arkansas.
 
Joining AHA in the Nov. 15 filings were 340B Health, the Mississippi Hospital Association, the Rural Hospital Alliance and the American Society for Health-system Pharmacists.

Headline
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B…
Headline
The Department of Health and Human Services and the Department of Justice Oct. 22 announced a six-month anti-fraud healthcare self-disclosure pilot program for…
Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…
Headline
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging…
Headline
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…